Thus, the safety profile of these drugs continues to evolve and more long-term data will be needed to understand exactly how safe these drugs are for patients that take them for the long-term
Hepatic mRNA abundance (relative to Actb ) for genes associated with ( E ) hepatic gluconeogenesis ( Gck , G6p , Pck , Gsk3 , and Pygl ) and ( F ) insulin signaling ( Gcgr , Igf1 , and Igf1r ) in Dpp4 +/+ ( n = 11) and Dpp4 / ( n = 7) mice
More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build muscle, rejuvenate skin and extend life, the latest example of the nation's fascination with alternative therapies and wellness hacks
On April 17, Eli Lilly announced that its drug orforglipron became the first oral GLP-1 to successfully complete a Phase 3 trial for safety and efficacy for people with diabetes and obesity